100 related articles for article (PubMed ID: 35643419)
1. Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi.
Hezagira N; Youngkong S; Riewpaiboon A
Int J Health Policy Manag; 2022 Dec; 11(12):2990-2999. PubMed ID: 35643419
[TBL] [Abstract][Full Text] [Related]
2. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
Niyibitegeka F; Riewpaiboon A; Youngkong S; Thavorncharoensap M
Vaccine; 2021 Feb; 39(8):1272-1282. PubMed ID: 33487467
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of Community Case Management of Childhood Diarrhea in Burundi.
Niyibitegeka F; Riewpaiboon A; Sangroongruangsri S
Value Health Reg Issues; 2021 Sep; 25():157-164. PubMed ID: 34218086
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.
Mori AT; Ngalesoni F; Norheim OF; Robberstad B
Malar J; 2014 Sep; 13():363. PubMed ID: 25223864
[TBL] [Abstract][Full Text] [Related]
5. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia: a dose-response study using routine health information system data.
Ashton RA; Hamainza B; Lungu C; Rutagwera MI; Porter T; Bennett A; Hainsworth M; Burnett S; Silumbe K; Slater H; Eisele TP; Miller JM
Malar J; 2023 Mar; 22(1):96. PubMed ID: 36927440
[TBL] [Abstract][Full Text] [Related]
7. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
8. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
9. Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi.
Niyibitegeka F; Thavorncharoensap M; Riewpaiboon A; Youngkong S
Appl Health Econ Health Policy; 2022 Sep; 20(5):707-716. PubMed ID: 35469393
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
Diawara H; Walker P; Cairns M; Steinhardt LC; Diawara F; Kamate B; Duval L; Sicuri E; Sagara I; Sadou A; Mihigo J; Eckert E; Dicko A; Conteh L
Malar J; 2021 Mar; 20(1):128. PubMed ID: 33663488
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
Pembet Singana B; Casimiro PN; Matondo Diassivi B; Kobawila SC; Youndouka JM; Basco LK; Ringwald P; Briolant S; Ndounga M
Malar J; 2022 May; 21(1):137. PubMed ID: 35501861
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016.
Diarra Y; Koné O; Sangaré L; Doumbia L; Haidara DBB; Diallo M; Maiga A; Sango HA; Sidibé H; Mihigo J; Nace D; Ljolje D; Talundzic E; Udhayakumar V; Eckert E; Woodfill CJ; Moriarty LF; Lim P; Krogstad DJ; Halsey ES; Lucchi NW; Koita OA
Malar J; 2021 May; 20(1):235. PubMed ID: 34034754
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis.
Pfeil J; Borrmann S; Tozan Y
PLoS One; 2014; 9(4):e95681. PubMed ID: 24748395
[TBL] [Abstract][Full Text] [Related]
14. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
[TBL] [Abstract][Full Text] [Related]
15. Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar.
Rakotoarisoa MA; Fenomanana J; Dodoson BT; Andrianaranjaka VHI; Ratsimbasoa A
Malar J; 2022 Nov; 21(1):331. PubMed ID: 36376921
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of malaria control in sub-Saharan Africa.
Goodman CA; Coleman PG; Mills AJ
Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
[TBL] [Abstract][Full Text] [Related]
18. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
Mori AT; Norheim OF; Robberstad B
Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
[TBL] [Abstract][Full Text] [Related]
19. Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction.
Gerstl S; Cohuet S; Edoh K; Brasher C; Lesage A; Guthmann JP; Checchi F
Malar J; 2007 Jul; 6():94. PubMed ID: 17640357
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Marwa K; Kapesa A; Baraka V; Konje E; Kidenya B; Mukonzo J; Kamugisha E; Swedberg G
PLoS One; 2022; 17(3):e0264339. PubMed ID: 35271592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
